Clinical Trial

Fecal Microbiota Transplantation for Ulcerative Colitis

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. Fecal microbiota transplantation has been used for several disease,but the efficacy of ulcerative colitis(UC) by fecal microbiota transplantation needs to be further explored.The investigators propose to determine the efficiency and safety of FMT in patients with ulcerative colitis(UC).
Trial Details
NCT Number NCT03804931
Lead Sponsor Guangzhou First People's Hospital
Conditions Ulcerative Colitis, Fecal Microbiota Transplantation
Enrollment 120 participants
Start Date 2019-01-20
Primary Completion 2028-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2019-01-15